DCM
MRTX

Deuterium Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Deuterium Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,000
Closed -$881K – 66
2023
Q4 		$881K Buy
+15,000
New +$881K 2.91% 8